Trial Profile
A feasibility study of postroperative adjuvant chemotherapy using platinum-based chemotherapy followed by maintenance TS-1 for completely resected pathologic stage II-IIIA non-small cell lung cancer with a biomarker study of circulating tumor cell.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Jan 2010
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Antineoplastics; Platinum complexes
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 12 Oct 2009 New trial record